In patients with migraine, NTG infusion leads to a more severe and persistent headache that fulfils diagnostic criteria for migraine without aura, and the migraine-like headache typically occurs at a delay of some hours following infusion [88,89]. The gene discussed is OPA1; the disease is migraine disorder.